NASDAQ:DBVT DBV Technologies (DBVT) Stock Price, News & Analysis $10.27 -0.75 (-6.81%) Closing price 04:00 PM EasternExtended Trading$10.26 -0.01 (-0.10%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About DBV Technologies Stock (NASDAQ:DBVT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get DBV Technologies alerts:Sign Up Key Stats Today's Range$10.19▼$10.9950-Day Range$8.87▼$13.4452-Week Range$8.63▼$26.18Volume142,685 shsAverage Volume410,693 shsMarket Capitalization$645.78 millionP/E RatioN/ADividend YieldN/APrice Target$45.25Consensus RatingModerate Buy Company Overview DBV Technologies is a clinical-stage biopharmaceutical company focused on developing treatments for food allergies and other immune-mediated conditions. Founded in France, the company’s research centers on epicutaneous immunotherapy, an approach that delivers small amounts of an allergen through the skin using a patch. Its lead investigational program is Viaskin Peanut, a patch-based treatment being developed for peanut allergy. DBV has also conducted research into treatments for other conditions, including milk allergy and eosinophilic esophagitis. Its product candidates are investigational and are not approved treatments. DBV Technologies is headquartered in France and has operations in the United States. The company’s shares trade on Nasdaq under the symbol DBVT and on Euronext Paris.AI Generated. May Contain Errors. Read More DBV Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks77th Percentile Overall ScoreDBVT MarketRank™: 3.8667373162 of 5 starsDBV Technologies scored higher than 77% of companies evaluated by MarketBeat, and ranked 111th out of 877 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.3 / 5Analyst RatingModerate Buy Consensus RatingDBV Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on no strong buy ratings, 5 buy ratings, no hold ratings, and 1 sell rating.Upside PotentialDBV Technologies has a consensus price target of $45.25, representing about 340.6% upside from its current price of $10.27.Amount of Analyst CoverageDBV Technologies has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about DBV Technologies' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for DBV Technologies are expected to grow in the coming year, from ($2.22) to ($1.90) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of DBV Technologies is -3.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of DBV Technologies is -3.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioDBV Technologies has a P/B Ratio of 2.45. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.30% of the float of DBV Technologies has been sold short.Short Interest Ratio / Days to CoverDBV Technologies has a short interest ratio ("days to cover") of 1.67, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in DBV Technologies has recently decreased by 7.50%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDBV Technologies does not currently pay a dividend.Dividend GrowthDBV Technologies does not have a long track record of dividend growth. News and Social Media2.6 / 5News Sentiment1.11 News SentimentDBV Technologies has a news sentiment score of 1.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.59 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 2 news articles for DBV Technologies this week, compared to 3 articles on an average week. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, DBV Technologies insiders have not sold or bought any company stock.Percentage Held by Insiders1.06% of the stock of DBV Technologies is held by insiders.Percentage Held by Institutions71.74% of the stock of DBV Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about DBV Technologies' insider trading history. Receive DBVT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DBV Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DBVT Stock News HeadlinesDBV Technologies Highlights New Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 YearsNovember 12, 2026 | markets.businessinsider.comDBV Technologies: Down 55% Since April, Yet My $42 Fair Value Still HoldsNovember 6, 2026 | seekingalpha.comWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.November 16 at 1:00 AM | Base Camp Trading (Ad)DBV Technologies S.A. ADRNovember 5, 2026 | barrons.comDBV Technologies SA - American (DBVT) AI Stock AnalysisNovember 2, 2026 | tipranks.comDBV Technologies to Participate in Upcoming November Investor ConferencesNovember 2, 2026 | globenewswire.comDBV Technologies Earnings Call: BLA Milestone and RisksOctober 30, 2026 | tipranks.comAnalysts Are Bullish on These Healthcare Stocks: DBV Technologies SA – American (DBVT), Align Tech (ALGN)October 30, 2026 | theglobeandmail.comSee More Headlines DBVT Stock Analysis - Frequently Asked Questions How have DBVT shares performed this year? DBV Technologies' stock was trading at $19.17 at the start of the year. Since then, DBVT stock has decreased by 46.4% and is now trading at $10.27. How were DBV Technologies' earnings last quarter? DBV Technologies S.A. (NASDAQ:DBVT) issued its earnings results on Wednesday, October, 28th. The company reported ($0.70) EPS for the quarter, missing the consensus estimate of ($0.29) by $0.41. The firm earned $1.60 million during the quarter, compared to analyst estimates of $558 thousand. DBV Technologies had a negative net margin of 5,392.17% and a negative trailing twelve-month return on equity of 120.95%. Read the conference call transcript. When did DBV Technologies' stock split? Shares of DBV Technologies reverse split on the morning of Friday, November 29th 2024.The 1-5 reverse split was announced on Monday, November 11th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, November 28th 2024. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split. When did DBV Technologies IPO? DBV Technologies (DBVT) raised $93 million in an IPO on Wednesday, October 22nd 2014. The company issued 4,277,826 shares at a price of $21.64 per share. Who are DBV Technologies' major shareholders? Top institutional shareholders of DBV Technologies include Russell Investments Group Ltd. (0.13%), Cetera Investment Advisers (0.04%), China Universal Asset Management Co. Ltd. and Vontobel Holding Ltd. (0.02%). Insiders that own company stock include Bpifrance Epic, Pharis Mohideen and Adora Ndu. View institutional ownership trends. How do I buy shares of DBV Technologies? Shares of DBVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of DBV Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that DBV Technologies investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Alibaba Group (BABA), Bristol Myers Squibb (BMY), Salesforce (CRM), Pfizer (PFE) and Gilead Sciences (GILD). Company Calendar Last Earnings10/28/2026Today11/16/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 DBVT's financial health is in the Red zone, according to TradeSmith. DBVT has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:DBVT CIK1613780 Webwww.dbv-technologies.com Phone(315) 542-7878Fax33-1-43-26-10-83Employees125Year Founded2002Price Target and Rating Average Price Target for DBV Technologies$45.25 High Price Target$48.00 Low Price Target$40.00 Potential Upside/Downside+340.6%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage6 Analysts Profitability EPS (Trailing Twelve Months)($3.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$146.95 million Net Margins-5,392.17% Pretax Margin-5,361.66% Return on Equity-120.95% Return on Assets-88.35% Debt Debt-to-Equity RatioN/A Current Ratio3.24 Quick Ratio3.24 Sales & Book Value Annual Sales$5.64 million Price / Sales114.50 Cash FlowN/A Price / Cash FlowN/A Book Value$2.36 per share Price / Book4.35Miscellaneous Outstanding Shares62,880,000Free Float62,211,000Market Cap$645.78 million OptionableOptionable Beta-0.84 Social Links The 7 Best High-Yield Dividend Stocks for 2027Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.Get This Free Report This page (NASDAQ:DBVT) was last updated on 11/16/2026 by MarketBeat.com Staff. From Our PartnersA $247 tool for $7Bill Poulos is offering his $247 Instant Scanner for $7 in the Black Friday sale. It's one payment for a full ...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredYour Copy is on Hold (Claim it now)James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on E...Paradigm Press | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredSmall-Cap SMX is Taking its Technology into Multiple Trillion-Dollar Industries!SMX (NASDAQ: SMX) uses proprietary molecular-marking technology and a Digital Material Passport platform to gi...Smallcaps Daily | SponsoredThis Tech Could Be Bigger Than Apple, Amazon, and Microsoft CombinedA breakthrough technology backed by Elon Musk, Sam Altman and Jensen Huang could one day be worth more than Ap...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DBV Technologies S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share DBV Technologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.